Increased susceptibility of sepsis associated with CD143 deletion/insertion polymorphism in Caucasians: A meta analysis

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 10, 2014, Pages 6551-6558

  Yang, Hongming ^a   Wang, Yihe ^a   Liu, Lingying ^a   Hu, Quan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

CD143; Ins del polymorphism; Sepsis

Indexed keywords

ACE PROTEIN, HUMAN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE; CAUCASIAN; CHI SQUARE DISTRIBUTION; CHILD; ENZYMOLOGY; ETHNOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HOMOZYGOTE; HUMAN; META ANALYSIS; PHENOTYPE; RISK; RISK FACTOR; SEPSIS;

ADULT; AGE FACTORS; CHI-SQUARE DISTRIBUTION; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; SEPSIS;

EID: 84912096971     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 2009; 101: 1644-55.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007; 35: 1244-50.
3. Rittirsch D, Flierl MA and Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008; 8: 776-87.
4. Remick DG. Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr Pharm Des 2003; 9: 75-82.
5. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7.
6. Hotchkiss RS and Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006; 6: 813-22.
7. Thomas L. Germs. N Engl J Med 1972; 287: 553-5.
8. Namath A and Patterson AJ. Genetic polymorphisms in sepsis. Crit Care Nurs Clin North Am 2011; 23: 181-202.
9. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83: 536-45.
10. van der Poll T and Levi M. Crosstalk between inflammation and coagulation: the lessons of sepsis. Curr Vasc Pharmacol 2012; 10: 632-8.
11. Rossig L, Hermann C, Haendeler J, Assmus B, Zeiher AM, Dimmeler S. Angiotensin II-induced upregulation of MAP kinase phosphatase-3 mRNA levels mediates endothelial cell apoptosis. Basic Res Cardiol 2002; 97: 1-8.
12. Kamiyama M, Farragut KM, Garner MK, Navar LG, Kobori H. Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney. J Hypertens 2012; 30: 2365-72.
13. Ramkumar N, Stuart D, Ying J, Kohan DE. A possible interaction between systemic and renal angiotensinogen in the control of blood pressure. Am J Hypertens 2013; 26: 473-80.
14. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996; 58: 1268-78.
15. Abbas D, Ezzat Y, Hamdy E, Gamil M. Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus. Lupus 2012; 21: 103-10.
16. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
17. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
18. Felehgari V, Rahimi Z, Mozafari H, Vaisi-Raygani A. ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria. Mol Cell Biochem 2011; 346: 23-30.
19. Cogulu O, Onay H, Uzunkaya D, Gunduz C, Pehlivan S, Vardar F, Atlihan F, Ozkinay C, Ozkinay F. Role of angiotensin-converting enzyme gene polymorphisms in children with sepsis and septic shock. Pediatr Int 2008; 50: 477-80.
20. Spiegler J, Gilhaus A, Konig IR, Kattner E, Vochem M, Kuster H, Moller J, Muller D, Kribs A, Segerer H, Wieg C, Nikischin W, von der Wense A, Gebauer C, Herting E, Gopel W. Polymorphisms in the Renin-Angiotensin system and outcome of very-low-birthweight infants. Neonatology 2010; 97: 10-4.
21. Tsantes A, Tsangaris I, Kopterides P, Nikolopoulos G, Kalamara E, Antonakos G, Kapsimali V, Gialeraki A, Dimopoulou I, Orfanos S, Dima K, Travlou A, Armaganidis A. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients. Clin Chem Lab Med 2012; 50: 293-9.
22. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-12.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
24. Begg CB and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
25. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
26. Cardinal-Fernandez P, Ferruelo A, El-Assar M, Santiago C, Gómez-Gallego F, Martín-Pellicer A, Frutos-Vivar F, Peñuelas O, Nin N, Esteban A, Lorente JA. Genetic predisposition to acute respiratory distress syndrome in patients with severe sepsis. Shock 2013; 39: 255-60.
27. Cardinal-Fernandez P, Ferruelo A, El-Assar M, Santiago C, Gómez-Gallego F, Martín-Pellicer A, Frutos-Vivar F, Peñuelas O, Nin N, Esteban A, Lorente JA. Genetic predisposition to acute kidney injury induced by severe sepsis. J Crit Care 2013; 28: 365-70.
28. John Baier R, Loggins J and Yanamandra K. Angiotensin converting enzyme insertion/deletion polymorphism does not alter sepsis outcome in ventilated very low birth weight infants. J Perinatol 2005; 25: 205-9.
29. Dahmer MK, Randolph A, Vitali S, Quasney MW. Genetic polymorphisms in sepsis. Pediatr Crit Care Med 2005; 6: S61-73.
30. Bunker-Wiersma HE, Koopmans RP, Kuipers TW, Knoester H, Bos AP. Single nucleotide polymorphisms in genes of circulatory homeostasis in surviving pediatric intensive care patients with meningococcal infection. Pediatr Crit Care Med 2008; 9: 517-23.
31. Celik U YD, Celik T, et al. Relationship between angiotensin-converting enzyme gene polymorphism (insertion/deletion) and the clinical condition of sepsis in Turkish children. Turkiye Klinikleri J Med Sci 2010; 30: 591-597.
32. Davis SM, Clark EA, Nelson LT, Silver RM. The association of innate immune response gene polymorphisms and puerperal group A streptococcal sepsis. Am J Obstet Gynecol 2010; 202: 308 e1-8.
33. Villar J, Flores C, Pérez-Méndez L, Maca-Meyer N, Espinosa E, Blanco J, Sangüesa R, Muriel A, Tejera P, Muros M, Slutsky AS; GRECIA group; GEN-SEP group. Angiotensin-converting enzyme insertion/deletion polymorphism is not associated with susceptibility and outcome in sepsis and acute respiratory distress syndrome. Intensive Care Med 2008; 34: 488-95.
34. Lin MT and Albertson TE. Genomic polymorphisms in sepsis. Crit Care Med 2004; 32: 569-79.
35. Rice CL, Kohler JP, Casey L, Szidon JP, Daise M, Moss GS. Angiotensin-converting enzyme (ACE) in sepsis. Circ Shock 1983; 11: 59-63.
36. Phillips MI and Kagiyama S. Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs 2002; 3: 569-77.
37. Clark MF and Baudouin SV. A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med 2006; 32: 1706-12.
38. Salanti G, Sanderson S and Higgins JP. Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 2005; 7: 13-20.
39. Zhu X, McKenzie CA, Forrester T, Nickerson DA, Broeckel U, Schunkert H, Doering A, Jacob HJ, Cooper RS, Rieder MJ. Localization of a small genomic region associated with elevated ACE. Am J Hum Genet 2000; 67: 1144-53.
40. Cox R, Bouzekri N, Martin S, Southam L, Hugill A, Golamaully M, Cooper R, Adeyemo A, Soubrier F, Ward R, Lathrop GM, Matsuda F, Farrall M. Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet 2002; 11: 2969-77.
41. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC. ACE polymorphisms. Circ Res 2006; 98: 1123-33.
42. Bloem LJ, Manatunga AK and Pratt JH. Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 1996; 27: 62-6.